---
title: "Kepler Capital  Remains a Buy on Novartis AG (NOVN)"
type: "News"
locale: "en"
url: "https://longbridge.com/en/news/285825757.md"
description: "Kepler Capital analyst David Evans has maintained a Buy rating on Novartis AG (NOVN) as of May 8, with a price target of CHF135.00. The stock closed at CHF113.36 last Friday. Additionally, Bank of America Securities also issued a Buy rating on Novartis AG, while UBS maintained a Hold rating on the same date."
datetime: "2026-05-10T01:58:39.000Z"
locales:
  - [zh-CN](https://longbridge.com/zh-CN/news/285825757.md)
  - [en](https://longbridge.com/en/news/285825757.md)
  - [zh-HK](https://longbridge.com/zh-HK/news/285825757.md)
---

# Kepler Capital  Remains a Buy on Novartis AG (NOVN)

Kepler Capital analyst David Evans maintained a Buy rating on Novartis AG on May 8 and set a price target of CHF135.00. The company’s shares closed last Friday at CHF113.36.

### Claim 55% Off TipRanks

-   Unlock hedge fund-level data and powerful investing tools for smarter, sharper decisions
-   Discover top-performing stock ideas and upgrade to a portfolio of market leaders with Smart Investor Picks

According to TipRanks, Evans is ranked #7060 out of 12193 analysts.

In addition to Kepler Capital , Novartis AG also received a Buy from Bank of America Securities’s Sachin Jain in a report issued on May 7. However, on May 8, UBS maintained a Hold rating on Novartis AG (Six Swiss: NOVN).

### Related Stocks

- [NOT.DE](https://longbridge.com/en/quote/NOT.DE.md)
- [NVS.US](https://longbridge.com/en/quote/NVS.US.md)
- [FBT.US](https://longbridge.com/en/quote/FBT.US.md)
- [IHE.US](https://longbridge.com/en/quote/IHE.US.md)
- [VHT.US](https://longbridge.com/en/quote/VHT.US.md)
- [SBIO.US](https://longbridge.com/en/quote/SBIO.US.md)
- [XLV.US](https://longbridge.com/en/quote/XLV.US.md)
- [BBH.US](https://longbridge.com/en/quote/BBH.US.md)
- [BIB.US](https://longbridge.com/en/quote/BIB.US.md)
- [LABU.US](https://longbridge.com/en/quote/LABU.US.md)
- [IXJ.US](https://longbridge.com/en/quote/IXJ.US.md)
- [ARKG.US](https://longbridge.com/en/quote/ARKG.US.md)
- [XBI.US](https://longbridge.com/en/quote/XBI.US.md)
- [PBE.US](https://longbridge.com/en/quote/PBE.US.md)
- [BAC.US](https://longbridge.com/en/quote/BAC.US.md)
- [UBS.US](https://longbridge.com/en/quote/UBS.US.md)
- [BAC-Q.US](https://longbridge.com/en/quote/BAC-Q.US.md)
- [BML-L.US](https://longbridge.com/en/quote/BML-L.US.md)
- [BAC-L.US](https://longbridge.com/en/quote/BAC-L.US.md)
- [BAC-K.US](https://longbridge.com/en/quote/BAC-K.US.md)
- [BML-H.US](https://longbridge.com/en/quote/BML-H.US.md)
- [BAC-N.US](https://longbridge.com/en/quote/BAC-N.US.md)
- [BAC-E.US](https://longbridge.com/en/quote/BAC-E.US.md)
- [MER-K.US](https://longbridge.com/en/quote/MER-K.US.md)
- [BAC-O.US](https://longbridge.com/en/quote/BAC-O.US.md)
- [BML-G.US](https://longbridge.com/en/quote/BML-G.US.md)
- [BAC-M.US](https://longbridge.com/en/quote/BAC-M.US.md)
- [BAC-B.US](https://longbridge.com/en/quote/BAC-B.US.md)
- [BML-J.US](https://longbridge.com/en/quote/BML-J.US.md)
- [BAC-S.US](https://longbridge.com/en/quote/BAC-S.US.md)
- [BAC-P.US](https://longbridge.com/en/quote/BAC-P.US.md)
- [8648.JP](https://longbridge.com/en/quote/8648.JP.md)

## Related News & Research

- [Acrivon Therapeutics, Inc. (ACRV) Receives a Buy from Oppenheimer](https://longbridge.com/en/news/286428001.md)
- [Roth MKM Sticks to Their Buy Rating for Capricor Therapeutics (CAPR)](https://longbridge.com/en/news/286497683.md)
- [LifeSci Capital Sticks to Their Buy Rating for Tenax Therapeutics (TENX)](https://longbridge.com/en/news/286648286.md)
- [Analyst Reiterates Buy on Corbus, Maintains $38 Price Target on CRB-701 Oncology Potential](https://longbridge.com/en/news/286284525.md)
- [Sanofi says rare lung disease drug outperforms standard care in trial](https://longbridge.com/en/news/286810610.md)